Deletion of TRPC6 Attenuates NMDA Receptor-Mediated Ca2+ Entry and Ca2+-Induced Neurotoxicity Following Cerebral Ischemia and Oxygen-Glucose Deprivation by Jin Chen et al.
ORIGINAL RESEARCH
published: 28 March 2017
doi: 10.3389/fnins.2017.00138
Frontiers in Neuroscience | www.frontiersin.org 1 March 2017 | Volume 11 | Article 138
Edited by:
Yulong Li,
University of Nebraska Medical
Center, USA
Reviewed by:
Huiyin Tu,
Zhengzhou University, China
De-Pei Li,
University of Texas MD Anderson
Cancer Center, USA
*Correspondence:
Zixi Cheng
zixi.cheng@ucf.edu
Specialty section:
This article was submitted to
Neuropharmacology,
a section of the journal
Frontiers in Neuroscience
Received: 21 January 2017
Accepted: 06 March 2017
Published: 28 March 2017
Citation:
Chen J, Li Z, Hatcher JT, Chen Q-H,
Chen L, Wurster RD, Chan SL and
Cheng Z (2017) Deletion of TRPC6
Attenuates NMDA Receptor-Mediated
Ca2+ Entry and Ca2+-Induced
Neurotoxicity Following Cerebral
Ischemia and Oxygen-Glucose
Deprivation. Front. Neurosci. 11:138.
doi: 10.3389/fnins.2017.00138
Deletion of TRPC6 Attenuates NMDA
Receptor-Mediated Ca2+ Entry and
Ca2+-Induced Neurotoxicity
Following Cerebral Ischemia and
Oxygen-Glucose Deprivation
Jin Chen 1, Zhaozhong Li 1, Jeffery T. Hatcher 1, Qing-Hui Chen 2, Li Chen 3,
Robert D. Wurster 4, Sic L. Chan 1 and Zixi Cheng 1, 5*
1Division of Neuroscience, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida,
Orlando, FL, USA, 2Department of Kinesiology and Integrative Physiology, Michigan Technological University, Houghton, MI,
USA, 3Department of Clinical Laboratory, The First Central Hospital of Tianjin, Tianjin, China, 4Department of Cellular and
Molecular Physiology, Stritch School of Medicine, Loyola University, Maywood, IL, USA, 5Division of Metabolic and
Cardiovascular Sciences, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando,
FL, USA
Transient receptor potential canonical 6 (TRPC6) channels are permeable to Na+
and Ca2+ and are widely expressed in the brain. In this study, the role of TRPC6
was investigated following ischemia/reperfusion (I/R) and oxygen-glucose deprivation
(OGD). We found that TRPC6 expression was increased in wild-type (WT) mice cortical
neurons following I/R and in primary neurons with OGD, and that deletion of TRPC6
reduced the I/R-induced brain infarct in mice and the OGD- /neurotoxin-induced
neuronal death. Using live-cell imaging to examine intracellular Ca2+ levels ([Ca2+]i),
we found that OGD induced a significant higher increase in glutamate-evoked Ca2+
influx compared to untreated control and such an increase was reduced by TRPC6
deletion. Enhancement of TRPC6 expression using AdCMV-TRPC6-GFP infection in WT
neurons increased [Ca2+]i in response to glutamate application compared to AdCMV-
GFP control. Inhibition of N-methyl-d-aspartic acid receptor (NMDAR) with MK801
decreased TRPC6-dependent increase of [Ca2+]i in TRPC6 infected cells, indicating
that such a Ca2+ influx was NMDAR dependent. Furthermore, TRPC6-dependent Ca2+
influx was blunted by blockade of Na+ entry in TRPC6 infected cells. Finally, OGD-
enhanced Ca2+ influx was reduced, but not completely blocked, in the presence of
voltage-dependent Na+ channel blocker tetrodotoxin (TTX) and dl-α-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid (AMPA) blocker CNQX. Altogether, we concluded that
I/R-induced brain damage was, in part, due to upregulation of TRPC6 in cortical neurons.
We postulate that overexpression of TRPC6 following I/R may induce neuronal death
partially through TRPC6-dependent Na+ entry which activated NMDAR, thus leading
to a damaging Ca2+ overload. These findings may provide a potential target for future
intervention in stroke-induced brain damage.
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INTRODUCTION
Ischemic stroke is a devastating disease that is one of the
leading causes of death. A critical deficit of cerebral blood flow
(CBF) during stroke rapidly triggers neuronal depolarization
that releases a large amount of glutamate into the extracellular
space (Drejer et al., 1985; Choi et al., 1990; Choi, 1992).
Glutamate binds to and activates dl-α-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid (AMPA) receptors and N-
methyl-d-aspartic acid (NMDA) receptors (McLennan, 1983;
Choi, 1988a,b). Overactivation of the AMPA and NMDA
receptors opens their associated ion channels to produce an
increased influx of Na+ and Ca2+, leading to an ionic imbalance
within neurons (Choi, 1993; Arundine and Tymianski, 2004).
Ca2+ overload has been shown to be related to Na+ entry
(Yu and Salter, 1998; Yu, 2006). It is well established that
the loss of homeostasis of Na+ and Ca2+ plays an important
role in ischemia-induced neuronal damage (Breder et al., 2000;
Bano and Nicotera, 2007). Thus, over-stimulation of glutamate
receptors can be considered as a primary intracellular event
that induces neuronal death in stroke. Likewise, upon oxygen
and glucose deprivation (OGD) which is a well-established
in vitro model of ischemia (Tasca et al., 2015), glutamate is
massively released by neurons, and the resulting increase in
the intracellular Ca2+ concentration ([Ca2+]i) causes a delayed
neuronal cell death (Caldeira et al., 2014). Therefore, treatments
which blocks glutamate-ionotropic receptors can protect neurons
from ischemic insult and reduce brain infarction in animals
(Choi et al., 1988; Chen et al., 1992). Similarly, Ca2+ uptake
and neuronal cell death following OGD can also be prevented
by the NMDA receptor (NMDAR) antagonist (Goldberg and
Choi, 1993). Though the blockade of glutamate receptors shows
dramatic neuroprotective effects in animal stroke and in vitro
OGD models, clinical trials aimed at reducing ischemic brain
injury by targeting NMDA and AMPA receptors, failed to achieve
satisfactory effects (De Keyser et al., 1999; Gladstone et al., 2002;
Lo et al., 2003). Therefore, there is a great need to develop new,
potential drug targets for the treatment of strokes (Roth and
Liesz, 2016).
More recent studies have indicated the existence of other
routes of ionic entry and imbalance within the injured neurons,
such as involving the transient receptor potential (TRP) family,
in particular, the melastatin subfamily of TRP proteins (TRPM).
TRPM7 is a well-studied protein among this subfamily which
has been shown to be linked with ischemia injured neurons
(Aarts and Tymianski, 2005). TRPM7 is a non-selective cation
channel that conducts both monovalent ions (Na+ and K+) and
divalent ions (Ca2+, Mg2+ and other trace metal ions) (Bae and
Sun, 2011). TRPM7 channels have been reported as an essential
mediator of anoxic neuronal death due to its Ca2+-permeable,
non-selective cation channel characteristics (Aarts et al., 2003;
MacDonald and Jackson, 2007). Suppression of hippocampal
TRPM7 channels could prevent neuronal death in brain ischemia
(Sun et al., 2009). Carvacrol, acting as a TRPM7 inhibitor,
protects brain from neonatal hypoxic-ischemic injury (Chen
et al., 2015). Thus, TRPM7 becomes a promising therapeutic
target for stroke treatment (Bae and Sun, 2011, 2013).
The other member of the TRP family, canonical subfamily of
TRP proteins (TRPC) subfamily is also permeable to Na+ and
Ca2+ non-selectively (Eder et al., 2005; Bush et al., 2006). The
TRPC family is comprised of seven different channels (TRPC1-
TRPC7) that are broadly expressed (Khairatkar-Joshi et al., 2015;
Ong et al., 2016). Among them, several TRPCs (TRPC1, 3, 4,
5, and 6) are expressed in the nervous system and play roles
in neuronal growth, path finding, and differentiation (Montell
et al., 2002; Riccio et al., 2002). TRPCs play a prominent role
in fundamental cellular events ranging from transcriptional
regulation to cell proliferation and death (Birnbaumer et al.,
1996; Montell et al., 2002). In particular, TRPC6 is a member
of the TRPC subfamily. Similar to TRPM7, TRPC6 channels
are non-selective cation channels that are permeable to Na+
and Ca2+. Though many aspects of the physiology and
regulation of TRPC6 are still elusive, an increasing number
of important pathological conditions are now being linked to
TRPC6 dysfunctions (Dietrich and Gudermann, 2014). TRPC6
has been shown to contribute to the sustained Ca2+ elevation that
is responsible for glioma proliferation (Bomben and Sontheimer,
2008; Ding et al., 2010), hypertrophic growth of cardiomyocytes
(Bush et al., 2006; Kuwahara et al., 2006; Onohara et al., 2006;
Nishida and Kurose, 2008), proteinuric kidney disease (Möller
et al., 2007) and pulmonary hypertension (Lin et al., 2004;
Weissmann et al., 2006). Activation of TRPC6was responsible for
lung ischemia-reperfusion induced edema in mice (Weissmann
et al., 2012) and high glucose- or oxidative stress-induced
podocyte ischemic injury (Yang et al., 2013; Zhao et al., 2015) and
downregulation of TRPC6 by Klotho showed cardioprotective
effects in the mouse heart (Xie et al., 2012).
TRPC6 channels are localized at the excitatory synapses and
may regulate neuronal excitability (Zhou et al., 2008). Activation
of TRPC6 channels is not dependent upon depolarization
(Montell et al., 2002; Ramsey et al., 2006). Since TRPC6 channels
are permeable to Na+ and Ca2+, we hypothesized that ischemic
stroke and OGD may increase TRPC6 expression which may, in
turn, activate NMDA receptors (NMDAR) and enhance Ca2+
influx. Thus, deletion of TRPC6 would be expected to reduce
ischemia-induced brain damage and OGD-/glutamate-induced
cortical cell death. Our study has demonstrated that TRPC6-
mediated Ca2+ influx enhanced excitotoxicity by facilitation of
NMDAR activation and TRPC6 deletion attenuated ischemia-
induced neuronal death.
MATERIALS AND METHODS
Materials
EBSS (Earle’s Balanced Salt Solution), Hank’s buffer, Glutamax,
and penicillin-streptomycin, Trizol, SuperScript II RNaseH
reverse transcriptase and T-PER buffer were purchased
from Invitrogen. GoTaq Green was obtained from Promega.
Neurobasal medium, B27, Dulbecco’s Modified Eagle Medium
(DMEM), and bovine calf serum were purchased from Hyclone.
2, 3, 5-triphenyltetrazolium chloride (TTC), propidium iodide
(PI), protease inhibitor cocktail, N-methyl-D-glucamine
(NMDG) and Trypan blue were obtained from Sigma.
Other reagents include: CNQX, MK801 (Molecular Probes);
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tetrodotoxin (TTX, Alamone); Fura-2 acetoxymethyl ester
(Fura-2 AM, Molecular Probes). Recombinant adenoviruses
AdCMV-GFP and AdCMV-TRPC6-GFP-Myc-tag were kindly
provided by Dr. Christopher B. Newgard. The sources of the
primary antibodies were as following: TRPC6 (Sigma, Lot#
8831P1), MAP2 (Cell Signaling, #4542), and Beta-Actin (Abcam,
ab8227). The goat anti-rabbit and anti-mouse secondary
antibodies conjugated to horse radish peroxidase were from
Jackson Immunoresearch.
Animals
Wild type WT mice (C57 BL/6J) were used as the background
to generate TRPC6−/− mice. The generation of TRPC6−/−
mice has been previously described (Dietrich et al., 2005). The
TRPC6−/− mice have been obtained from Dr. Lutz Birnbaumer
(National Institute of Environmental Health Sciences) and were
housed in in the transgenic animal facility (TAF). One male
WT mouse was housed in the same cage with one female WT
mouse. Similarly, one male TRPC6−/− mouse was housed in
the same cage with one female TRPC6−/− mouse. The pregnant
mice were separated from the males and kept in a single cage as
soon as they showed signs of pregnancy. The pregnant mice were
checked daily. The animal protocol had been approved by UCF
IACUC. All experiments were conducted in accordance with the
recommendations of UCF IACUC.
Focal Cerebral Ischemia Model
TRPC6−/− and WT control mice were maintained on a 12
h light/12 h dark cycle with food and water. Three-four
month-old male mice were used for this experiment. The focal
cerebral ischemia/reperfusion model was generated following
that described previously (Culmsee et al., 2001; Arumugam
et al., 2006; Wei et al., 2011). Briefly, mice were anesthetized
with isofluorane (3–4% mixed with oxygen). The animals were
maintained under anesthetic using an anesthesia machine with
a scavenger until the completion of the surgery. The depth of
anesthesia was assessed by the amplitude of the leg twitch in
response to the pinch of the toes. A midline incision was made in
the neck, and the left external carotid and pterygopalatine arteries
were isolated and ligated with 5-0 silk thread. The internal
carotid artery (ICA) was occluded with a small clip applied at
a site that was peripheral to the bifurcation of the ICA and
the pterygopalatine artery. The common carotid artery (CCA)
was ligated with 5-0 silk thread. The external carotid artery
(ECA) was cut, and the tip of a 6-0 nylon monofilament was
inserted into the ECA. After the clip at the ICA was removed,
this nylon thread was advanced into the middle cerebral artery
(MCA) until light resistance was felt. The nylon thread and the
CCA ligature were removed after 60 min of occlusion to initiate
reperfusion. CBF was measured using a laser Doppler perfusion
monitor and all CBF measurements were conducted with the
mouse fixed in a plastic frame with the probe placed in the
region of cerebral cortex perfused by the MCA as previously
described (Arumugam et al., 2006). All surgical instruments were
autoclaved prior to use. The animals were placed on a heating
pad during the surgery and recovery from anesthesia, during
which time the animals were be closelymonitored. Post-operative
pain was relieved using buprenorphine (0.03 mg/kg body weight;
IP). Analgesia was given post-op prior recovery from anesthesia
and then every 12 h for 2 days. The animals were euthanized at
various time points (12, 18, 24, 48, 72 h after the surgery), and the
ipsilateral and contralateral cortices of their brains were removed
for immunohistochemical and biochemical analyses.
Quantification of Cerebral Infarction
After 24 h of reperfusion, the mice were euthanized with
isofluorane (5% mixed with oxygen). The brains were
immediately removed and placed into ice-cold PBS for 15
min, and then 2-mm coronal sections were cut. The brain
sections were stained with TTC (2%) in PBS at 37◦C for 15
min. The stained sections were photographed, and the digitized
images were used for analysis. The borders of the infarct in each
brain slice were outlined, and the area quantified using an ImageJ
software. Infarct volume was calculated by integration of infarct
areas for all slices of each brain (Arumugam et al., 2006; Tu et al.,
2010; Pei et al., 2015).
Primary Cortical Neuronal Cultures
Primary cultures of mouse cortical neurons were prepared from
the 18-day-old fetuses of pregnant female mice as previously
described (Brewer et al., 1993; Brewer, 1997; Szychowski et al.,
2015). Briefly, brain cortices were harvested by removal of the
brainstem and hippocampus followed by mechanical trituration.
After the dissected tissue was minced and gently digested
with trypsin, the cells were suspended in Neurobasal medium
(Gibco) supplemented with 2% B-27 supplement (Invitrogen),
2mM glutamax, and 1% antibiotic (50 U/mL penicillin, and
0.05mg/mL streptomycin). This procedure typically yields cell
cultures that contain about 90% neurons and 10% astrocytes
(Kajta et al., 2004). Live cells were identified using Typan blue
staining and counted. The cells were seeded at a density of 5 ×
105 cells per well in 6 well plate (all plates were pre-coated with
poly-D-lysine) and maintained at 37◦C with 5% CO2. Half of the
mediumwas changed every 3 days, and the cells were cultured for
14-16 days.
Oxygen-Glucose Deprivation
After 14–16 days of culture, the primary cortical neurons
were challenged with oxygen-glucose deprivation (OGD)
(Goldberg and Choi, 1993). OGD was induced by washing
and incubating the cultures in a pre-equilibrated glucose-free
balanced salt solution in the Billups-Rothenberg anaerobic
chamber containing 95% nitrogen and 5% CO2. The chamber
was sealed and incubated for 2 h at 37◦C. At the end of the
procedure, culture medium was removed and replaced with
serum-containing Neurobasal medium prior to returning the
neuronal cultures to normoxia (95% oxygen and 5% CO2) for 24
h. Control cultures were incubated for 2 h in a similar balanced
salt solution containing 5.5 mM glucose under normoxic
conditions.
RT-PCR
Total RNA was extracted from the ipsilateral and contralateral
cortices of the brain tissue using Trizol reagent following the
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manufacture’s protocol. Reverse transcription was started with
2µg of total RNA at 42◦C for 60min in 20µL reaction mixture
containing 20 U RNase inhibitor, 0.25 mM of each dNTP, 0.5µg
Oligo(dT)15, 200 U SuperScript II RNaseH reverse transcriptase.
Synthesized first-strand cDNA was then amplified by PCR in
25µL reaction volume, containing 5µL DNA template, 12.5µL
GoTaq Green Master Mix, a pair of primer for TRPC6 and
inner control β-actin, respectively (10 pmol per primer). An
appropriate cycle number was chosen to avoid the accumulation
of by-products and yield accurate replication of target DNA
before the characteristic plateau phase was reached in the PCR
amplification curve. PCR procedure included: pre-denatured
at 95◦C for 5min; amplification at 95◦C 50 s, 56◦C 1min,
72◦C 1min; and extended at 72◦C for 10min. Aliquots of the
PCR product were separated using agarose gel electrophoresis
and visualized with ethidium bromide staining. The following
oligonucleotide primers were used: for TRPC6, sense 5′-CAG
ATC ATC TCT GAA GGT CTT TAT GC-3′ and anti-sense
5′-TGT GAA TGC TTC ATT CTG TTT GCG CC-3′; for β-
actin, sense 5′-TGC TAT CCC TGT ACG CCT CT-3′, anti-sense
5′-GGA GGA GCA ATG ATC TTG A-3′.
Western Blot
Protein from ipsilateral and contralateral cortices was extracted
using T-PER tissue protein extraction buffer with protease
inhibitor cocktail (Sigma). Protein concentration was determined
using the BCA protein assay kit (Pierce, USA). Fifty µg of
protein was separated by SDS-PAGE (8–12%) and transferred
to nitrocellulose membranes. The membranes were blocked in
5% non-fat milk for 1 h at room temperature, followed by
an overnight incubation at 4◦C with antibodies raised against
TRPC6 or β-actin. Membranes were then washed and incubated
with secondary antibodies for 1 h at room temperature. Protein
bands were visualized using a chemiluminescence detection kit
(Amersham Biosciences).
Adenoviral Transduction
For adenovirus construction, cytomegalovirus (CMV) promoter-
driven human Myc-tagged TRPC6 adenovirus was constructed
by cloning cDNA constructs into the pAdTrack shuttle vector
and using the Ad-Easy system to generate the recombinant
adenoviruses as previously described (He et al., 1998; Hayes et al.,
2013). Approximately 14–16 days after cortical neuron seeding,
the mediumwas removed and cells were transduced at viral doses
of up to 20 pfu/cell for 4 h (Robert et al., 1997). After the virus-
containing medium was removed, the fresh medium was added.
At 24-h intervals, cells were collected for the experiments.
Quantification of Neuronal Death
Propidium iodide (PI) staining of nuclei (red) in primary
neurons from WT and TRPC6−/− mice following OGD, 100
µM glutamate or 50 µM NMDA pretreatment were performed.
Primary neuron cells were fixed with cold 70% ethanol,
permeabilized with 0.5% Triton X-100 in PBS for 5 min and
RNase treated (100 U/ ml; Sigma) at room temperature for
120 min. Nuclei were stained with 1 µg/ml propidium iodide
(PI; Sigma) for 10 min (Ito et al., 2004). For double-labeling
of the nuclei and cell body with dendrites, non-specific sites
were blocked with 5% BSA in PBS at room temperature for
60 min, and cells were incubated at 4◦C with rabbit MAP2
(Cell Signaling, #4542) overnight after fixation (Soltani et al.,
2005; Campbell et al., 2014). The cells were incubated with goat
anti-rabbit IgG (H+L), Alexa Fluor R© 488 (Invitrogen) for 60
min after washing 3 times. Then, nuclei were stained with 1
µg/ml propidium iodide (PI; Sigma) for 10 min). Coverslips
weremounted withmountingmedium containing anti-bleaching
agent and examined with a fluorescence microscope (Nikon 80i).
The number of PI-labeled bright condensed nuclei was counted
and expressed as the percentage of the total number of PI positive
cells counted, indicating the percent of cell death. All experiments
were repeated using at least three independent cultures.
Intracellular Ca2+ Imaging
After 14–16 days of culture, these neurons were loaded with the
fluorescent dye Fura-2 acetoxymethyl ester (Fura-2 AM) (3µM)
for 30min in humidified 5% CO2 incubator at 37
◦C, washed 3
times in HEPES-KRH buffer (116mM NaCl, 4mM KCl, 1 mM
MgCl2, 1.8 mM CaCl2, 25 Mm Glucose, 10 mM HEPES, pH
7.4) and incubated for additional 30 min. Then, the changes
in free intracellular Ca2+ concentration ([Ca2+]i) in neurons
loaded with Fura-2 were recorded and measured using the Nikon
Live Image System with Nikon Elements software (Nis-Elements
AK 4.13). Images were taken every 10 s with an exposure time
of 200 ms. Fura-2 dual excitation images were captured with
a camera (AnDor; Fluor 40× objective). The baseline Fura-2
fluorescence intensity (expressed as the ratio of 340/380 nm)
was measured 1 min before glutamate application. Glutamate
application (100µM) at 60 s after initiation of recording was used
to evoke Ca2+ influx. An increase in relative Fura-2 340/380
fluorescence indicates an increase in free intracellular Ca2+
concentration (Hirst et al., 2005; Barreto-Chang and Dolmetsch,
2009). The fluorescence intensity of primary neurons (ratio
of 340/380 nm) in each image frame was normalized relative
to the background intensity. Appropriate regions of interest,
representing a change in Ca2+ influx, were selected, and the
average ratio of fluorescence was represented in graphs. The
change of fluorescence intensity (F) of each neuron at the
different time points was normalized relative to the initial
intensity (F0) of that neuron at 0 s (before glutamate application).
The mean dynamic changes in [Ca2+]i were determined at each
time point for 3–10 neurons in each experiment.
Statistical Analysis
Values were represented as mean ± S.E.M. Student t-test was
used for comparison between two groups. Statistical comparisons
were performed using ANOVA and Newman-Keuls post-hoc test
for pairwise comparisons. Statistical significance was accepted at
P < 0.05.
RESULTS
Ischemia/Reperfusion (I/R) and OGD
Increased TRPC6 Expression
To determine whether ischemia altered the TRPC6 expression
level, we measured mRNA levels of TRPC6 in the brains
following I/R. We found that mRNA expression of TRPC6 was
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markedly upregulated, starting at 12 h after I/R in the ipsilateral,
but not in the contralateral cortices (Figure 1A). Analogously to
its transcript, TRPC6 protein levels were significantly higher in
the ipsilateral side than in the contralateral cortices (Figure 1B).
TRPC6 protein levels were also measured at 6, 12, and 24
h following OGD in primary cortical neurons. Immunoblot
showed a significant increase of the TRPC6 protein level in OGD-
treated cortical neurons 24 h after OGD treatment (Figure 1C),
that was consistent with the I/R mice as shown in Figure 1B.
These results demonstrated that I/R and OGD induced a
significant increase in TRPC6 expression in neurons.
TRPC6 Deletion Attenuated I/R-Induced
Brain Infarct Size and Protected Neurons
from OGD-Induced Cell Death
To determine whether TRPC6 plays a role in the brain infarct
size, we employed the I/R model in WT and TRPC6−/− mice.
Two days after I/R, wemeasured the amount of the brain damage.
We found that the infarct size was significantly decreased in the
TRPC6−/− mice compared to WT mice (Figure 2A), indicating
that TRPC6 deletion rendered the brain less susceptible to
the ischemic insults. To determine whether TRPC6 ablation
may alter physiologic variables that can influence the function
outcome in ischemic stroke, regional cerebral blood flow (rCBF)
was measured using a laser Doppler probe as previously
described (Arumugam et al., 2006). rCBF in the area blood-
supplied by MCA was reduced equivalently to near constant
values, averaging approximately 20% of normal flow. Upon
reperfusion, rCBF recovered both in WT and TRPC6−/− mice.
Hence, TRPC6 ablation does not affect rCBF before, during, or
after ischemia (Figure 2A).
To examine whether TRPC6 plays a role in OGD-induced
neuronal cell death, we challenged WT and TRPC6−/− cortical
neurons with OGD. Cell viability was assessed by PI staining
(red) that had bound to the nucleotide. The dying neurons
had the smaller size of nuclei (<2µM in diameter) than the
other neurons that have the normal size of nuclei (4–5 µM)
(Hezel et al., 2012). Compared to WT neurons challenged with
OGD, there were significantly fewer condensed PI-labeled nuclei
in TRPC6−/− neurons in the same condition (Figure 2B, Left,
Red). To further identify neurons, we used the neuron-specific
marker MAP2 to label cell body and dendrites (Figure 2B, Left,
Green). PI and MAP2 double-labeling of neurons with OGD
pretreatment were shown in Figure 2B, Left. These data showed
that deletion of TPRC6 significantly reduced the OGD-induced
neuronal cell death (as indicated by the bright shrinking nuclei
and lack of MAP2).
TRPC6−/− Protected against Glutamate or
NMDA-Induced Cell Death
To evaluate the role of TRPC6 in excitotoxic neuronal death,
we treated WT and TRPC6−/− cortical neuron cultures (14–
16 days) with glutamate (100µM) and NMDA (50µM) for 30
min, respectively. Twenty-four hours after glutamate or NMDA
treatment, the cultured neurons were fixed and cell viability was
assessed by PI staining (red). These results showed that glutamate
and NMDA significantly increased neuronal cell death compared
to normal untreated neurons. Deletion of TRPC6 significantly
protected neurons from glutamate and NMDA-induced cell
death (Figures 3A–C).
OGD Increased Ca2+ Influx in Response to
Glutamate and TRPC6 Deletion Decreased
OGD-Induced Ca2+ Overload
Because Ca2+ overload is one of the major contributors to
OGD-induced neuronal cell death (Goldberg and Choi, 1993;
Bruno et al., 1994; Honda et al., 1994), we next determined
whether TRPC6 deletion protects against OGD -induced Ca2+
influx. Figure 4A included original recordings of intracellular
Ca2+ level [Ca2+]i at different time frames in response to
glutamate application at 60 s after the start of recording (0
s) into the bath. Figures 4B,C showed the time course and
the peak of [Ca2+]i in response to glutamate application,
respectively. OGD pretreatment significantly increased [Ca2+]i
in neurons in both WT and TRPC6−/− neurons compared to
the [Ca2+]i level at the start of recording (0 s) where F/F0
equaled 1. Deletion of TRPC6 significantly attenuated OGD-
induced [Ca2+]i increase compared to control (P < 0.01). These
observations indicate that TRPC6 contributes to OGD-increased
Ca2+ influx.
Ca2+ Influx Was Enhanced in TRPC6
Overexpressed Neurons, Independent of
AMPA Receptors
To demonstrate whether TRPC6 could mediate Ca2+ influx
and whether such an influx was dependent on AMPA
channel receptors whose opening also increased the opening
probability of NMDA receptor channels (see below), WT cortical
neurons were infected for 4 h with AdCMV-TRPC6-GFP
to overexpress TRPC6 and AdCMV-GFP as control (normal
TRPC6 expression). Twenty-four hours after infection, neurons
showed GFP (green) (Figure 5A, last column) to confirm
the successful infection. Glutamate (100 µM) was applied
to a bath containing infected neurons in the presence of
the AMPA antagonist CNQX (10 µM) that could effectively
block AMPA receptors on the glutamate-induced [Ca2+]i
elevation (Dixon and Copenhagen, 1992; Regan and Choi,
1994). Different from the control group where the intracellular
Ca2+ level peaked at 60 s, [Ca2+]i was enhanced in response
to glutamate over the whole recording period (300 s) in
TRPC6 overexpressed neurons. In the presence of CNQX,
overexpression of TRPC6 still enhanced [Ca2+]i in response to
glutamate application, indicating TRPC6 could mediate Ca2+
influx in response to glutamate independent of AMPA receptors
(Figure 5B).
TRPC6 Overexpression-Induced [Ca2+]i
Increase Was Attributed to NMDAR
Activation
To determine whether the glutamate-evoked Ca2+influx
increase observed in TRPC6-infected neurons was attributable
to NMDAR activation, we applied NMDAR antagonist MK-801.
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FIGURE 1 | Ischemia/Reperfusion (I/R) and OGD increased TRPC6 expression. (A,B) Time course analysis of TRPC6 mRNA (A) and protein (B) expressions in
the ipsilateral and contralateral cortices of mice subjected to I/R. Quantitative analyses of the changes in TRPC6 mRNA and protein levels at the indicated time points
after I/R were determined by densitometry. Fold increases are relative to Sham (S). *P < 0.01 compared to corresponding values in the contralateral cortices (n =
4/group). (C) TRPC 6 protein in WT cortical neurons subjected to OGD. Immunoblotting was performed with 50 µg of total proteins and probed with antibodies to
TRPC6. β-actin was used as a loading control. Three independent experiments at each time point (n = 3). *P < 0.01, compared with control groups (0 h).
WT cortical neurons were infected with AdCMV-TRPC6-
GFP to enhance TRPC6 expression and AdCMV-GFP
for control. Glutamate (100µM) was applied to a bath
containing infected neurons in the presence of MK-801
(20µM) which could effectively block NMDAR receptor
mediated-, glutamate-induced [Ca2+]i increases (Wong
et al., 1986; Tasker et al., 1992). After glutamate application,
[Ca2+]i was evoked. TRPC6 overexpression significantly
increased glutamate evoked [Ca2+]i compared to the control
but MK-801 reduced such an increase (Figure 5C). Thus,
TRPC6 overexpression induced the glutamate evoked
[Ca2+]i elevation that is largely attributed to NMDAR
activation.
TRPC6 Overexpression-Mediated [Ca2+]i
Increase Was Attributed to Na+ Entry
Na+ influx regulates neuronal excitability and is responsible
for the initiation and propagation of action potentials (Yu and
Salter, 1998). NMDA receptor-mediated Ca2+ influx can be
enhanced by raising intracellular Na+ ([Na+]i) or activating
Na+-permeable channels (Taylor and Meldrum, 1995; Yu,
2006). To determine whether the activity of NMDAR may
be regulated by TRPC6 via the actions of Na+ entering
neurons, we examined glutamate-evoked Ca2+ levels in TRPC6
overexpressed neurons by completely eliminating Na+ in the
culture medium. Na+ was replaced by the large membrane-
impermeable cation N-methyl-D-glucamine (140 mM NMDG
replacing 140 mM NaCl) in the bath solution such that the
electrical charges and osmolality across the cell membrane
would not be changed (Storozhevykh et al., 1998). Again, WT
cortical neurons were infected with AdCMV-TRPC6-GFP to
enhance TRPC6 expression and infected with AdCMV-GFP as
control. After 24 h infection, [Ca2+]i was significantly enhanced
in TRPC6 overexpressed neurons compared to control group
(GFP) in response to glutamate application. NMDG replacement
significantly, but not completely, reduced such an increase
in TRPC6-infected neurons (Figure 5D). Thus, the glutamate-
evoked increase in [Ca2+]i was significantly reduced in TRPC6
overexpressed neurons in Na+-free bath, suggesting that TRPC6
induced [Ca2+]i increase was, at least partially, attributed to Na
+
entry to the neurons.
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FIGURE 2 | TRPC6 deletion attenuated I/R-induced brain infarct size and protected neurons from OGD-induced cell death. (A) Images of the brain
sections from WT and TRPC6−/− mice 24 h after a 60 min-MCAO that were stained with TTC. Bar graph shows the infarct volume. Infarct volume was calculated by
integration of infarct areas that were not stained by TTC for all slices of each brain. *P < 0.01 (n = 6 /group). Regional cerebral blood flow (rCBF) in TRPC6−/− and
WT mice at the indicated time points before (PRE), during 60 min MCAO and 45 min reperfusion (n = 3–4/group). rCBF was measured over the MCA territory by laser
Doppler flowmetry. Baseline rCBF measured before MCA occlusion was defined to be 100% flow. (B) Propidium iodide (PI) staining of nuclei and cell bodies (red) and
immunocytochemical labeling of MAP2 (green) of cell body and dendrites in primary neurons from WT and TRPC6−/− mice following OGD pretreatment. Scale bar,
10µm. The small, bright condensed nuclei (<2µm in diameter) without stomata and dendrites indicate dead neurons as indicated by arrows. Bar graph shows the
percentage of cell death in WT and TRPC6−/− primary neurons with or without OGD pretreatment *P < 0.01 (n = 3 independent experiments/group). In each
experiment, three wells and >100 neurons/well were counted.
OGD-induced [Ca2+]i Increase May Be
Attributed to Voltage-Sensitive Na+
Channels and AMPA Receptor Channels
As shown in Figure 4, TRPC6 mediated Ca2+ entry following
OGD. We further assessed whether OGD-induced increase in
[Ca2+]i was also mediated by other channels, e.g., voltage-
sensitive Na+ channels and AMPA receptor mediated channels,
voltage-sensitive Na+ blocker Tetrodotoxin (TTX, 0.1µM) was
applied to block voltage-sensitive Na+ channels in the presence
of AMPA receptor blocker CNQX (10µM) (Tasker et al.,
1992; Glazner et al., 2000; Tu et al., 2009). The Ca2+ influx
in response to glutamate application was measured in WT
cortical neurons with OGD pretreatment in presence of TTX
and CNQX, along with WT cortical neurons with or without
OGD. OGD induced [Ca2+]i increase was significantly reduced,
but not completely eliminated by TTX/CNQX in neurons
compared to the control neurons (WT) (Figure 6). In addition
to TRPC6 voltage-insensitive channels that contributed OGD-
enhanced Ca2+ influx, voltage-sensitive Na+ channels or/and
AMPA receptors may contribute to OGD-enhanced Ca2+ influx.
This indicates that Na+ entry via TRPC6, voltage-sensitive
Na+ channels and AMPA receptor channels all play a role in
facilitating depolarization-induced NMDAR activation during
OGD.
DISCUSSION
For decades, Ca2+ overload has been considered as one of
the major mechanisms underlying ischemia-induced neuronal
death. Blockers of NMDA receptors were used to reduce Ca2+
influx and showed protective effects on the brain damages in
animal stoke models. Unfortunately, multiple clinical trials of
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FIGURE 3 | TRPC6 deletion protected primary cortical neurons from glutamate- or NMDA-induced neuronal death.(A) Representative images using
propidium iodide (PI) staining in WT and TRPC6−/− primary neurons with glutamate (100µM) or NMDA (50µM) pretreatments, respectively. The small, bright
condensed nuclei (<2µm in diameter) (arrow) show the dying neurons. Scale bar, 10µm. (B,C) Cell death after glutamate and NMDA pretreatment in WT and
TRPC6−/− neurons. *P < 0.01 (n = 3 independent experiments/group). In each experiment, three wells and >100 neurons/well were counted.
FIGURE 4 | TRPC6 deletion decreased OGD-induced Ca2+ overload. (A) Ratiometric fluorescence images of Fura-2 loaded WT and TRPC6−/− primary
neurons in response to glutamate (100 µM) application with and without OGD pretreatments. Images were taken every 10 s during the recording. Intracellular [Ca2+]i
intensity is indicated by the ratio of 340/380 nm and encoded by pseudocolor as shown in the color bar. (B) Traces show the time course of [Ca2+]i which was
analyzed using the Nikon live cell imaging software. Glutamate was added as indicated by an arrow before 60 s. Ten neurons were sampled and analyzed in each
experiment. F/F0 is expressed as the Fura-2 fluorescence ratio 340/380 nm (F) relative to the initial fluorescence ratio (F0) at each time point. At time 0, F/F0 is 1. (C)
Bar graph shows the mean peaks of F/F0 traces of the 4 groups. *P < 0.01 (n = 3 independent experiments/group).
glutamate antagonists failed to show effective neuroprotection
and had serious side effects in stroke patients (Roth and
Liesz, 2016). There is an urgent need to develop new, effective
alternative targets for treatment. Here, the present study reports
that deletion of TRPC6 protects against cerebral I/R-induced
brain damage in vivo and OGD- and excitatory neurotoxin-
induced cell death in vitro. This protection is mediated, in part,
through the TRPC6 mediated NMDA receptors. Specifically,
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FIGURE 5 | Overexpression of TRPC6 increased glutamate-evoked Ca2+ influx in WT cortical neurons: effects of AMPA receptor antagonist, NMDA
receptor antagonist, and Na+-free medium. (A) AdCMV-GFP and AdCMV-TRPC6-GFP were infected WT neurons with GFP fluorescence which are indicated as
GFP in the right column. Ratiometric fluorescence images of Fura-2 AM loaded AdCMV-GFP (control) and AdCMV-TRPC6-GFP (TRPC6 overexpression) neurons after
glutamate (100µM). Images were taken every 10 s during recording. [Ca2+]i was analyzed using Fura-2 as ratio of 340/380 nm and encoded by pseudocolor as in
Figure 4. (B) AdCMV-TRPC6-GFP neurons exhibited a significantly higher glutamate-evoked [Ca2+]i increase compared to AdCMV-GFP control neurons in the
presence of the AMPA antagonist (10µM CNQX). The bar graph shows the peak of F/F0 in AdCMV-GFP and AdCMV-TRPC6-GFP neurons after glutamate. Three
neurons were collected per experiment. *P < 0.01 (n = 3 independent experiments/group). (C) TRPC6-mediated Ca2+ influx was blocked by an irreversible NMDAR
channel blocker MK-801 (20µM). The bar graph shows the peaks of F/F0 in AdCMV-GFP (control) and AdCMV-TRPC6-GFP (TRPC6 overexpression) infected neurons
treated with or without MK801 in response to glutamate (100µM) application. Three neurons per experiment were analyzed. n = 3 independent experiments/group. *P
< 0.01. (D) Glutamate-evoked increase in [Ca2+]i was significantly reduced in control (AdCMV-GFP) and AdCMV-TRPC6-GFP neurons after Na
+ was removed and
replaced by NMDG in the bath solution (Na+-free bath). The bar graph shows the peaks of F/F0 in AdCMV-GFP or AdCMV-TRPC6-GFP primary neurons treated with
or without NMDG replacement in response to glutamate. Three neurons per experiment were used. n = 3 independent experiments/group. *P < 0.01, #P < 0.05.
TRPC6 expression was increased in the brain tissues in the I/R
animal model and OGD-treated cortical neurons in culture. In
addition, deletion of TRPC6 protected I/R-induced brain damage
and OGD-induced neuronal death. Furthermore, deletion of
TRPC6 could also protect neurons against excitatory neurotoxin
(glutamate or NMDA)-induced cell death. To determine the
cellular and molecular mechanism for OGD-induced neuronal
death, OGD was found to increase, but deletion of TRPC6
reduced glutamate-evoked Ca2+ entry. TRPC6 overexpression
increased glutamate-evoked Ca2+ entry in the presence of the
AMPA blocker, indicating TRPC6-increased Ca2+ entry could
be independent of AMPA receptor channels. In the presence of
the NMDA receptor antagonist MK801, the increased glutamate-
evoked Ca2+ entry in TRPC6 overexpressed neurons was largely
reduced, indicating that NMDA receptors were involved. To
assess whether Na+ contributed to the TRPC6-enhaced Ca2+
influx, we found that glutamate-evoked Ca2+ entry in TRPC6
overexpressed neurons was largely reduced in Na+-free bath,
indicating that Na+ entry was required for TRPC6-mediated
Ca2+ influx. Finally, we found that glutamate-evoked Ca2+ entry
was reduced but not completely abolished in OGD-treated WT
neurons after blockade of voltage-sensitive Na+ channels and
AMPA receptor channels. We postulate that TRPC6 channels,
as well as other channels (e.g., voltage-sensitive Na+ channels),
may contribute to TRPC6-mediated Ca2+ influx, at least in
part, through NMDA receptor channels. Therefore, the present
data have demonstrated that overexpression of TRPC6 may
contribute to neuronal death partially throughNa+ entry, leading
to activation of NMDA receptors, thus causing an overload
of Ca2+.
The present results are consistent with several findings about
TRPC6 in different tissues and organs. Previously, it has been
demonstrated that hypoxia could drive glioblastoma multiforme
cells into a more aggressive and malignant state through Notch1-
induced TRPC6 overexpression which in turn activated the
calcineurin-nuclear factor of activated T-cell (NFAT) pathway
Frontiers in Neuroscience | www.frontiersin.org 9 March 2017 | Volume 11 | Article 138
Chen et al. The Role of TRPC6 in Ischemia and OGD-Induced Neurotoxicity
FIGURE 6 | OGD-induced [Ca2+]i increase may be attributed to voltage-sensitive Na+ channels and AMPA receptor channels. (A) Ca2+ influx in
OGD-pretreated WT primary neurons in response to glutamate (100 µM) application in the bath containing TTX (0.1 µM) and CNQX (10 µM) to block voltage-sensitive
channels and AMPA receptors. (B) Traces show the time course of the intracellular [Ca2+]i. (C) The bar graph shows the peaks of F/F0 traces. Ten neurons per
experiment were analyzed. n = 3 independent experiments/group. *P < 0.01.
and increased Ca2+ influx (Chigurapati et al., 2010). Later,
TRPC6−/−mice were found to be resistant to I/R-induced edema
in the lung (Weissmann et al., 2012). TRPC6-deficient mice
attenuated I/R -induced Ca2+ influx, cellular shape changes, and
barrier dysfunction in the lung. Along this line, it has been further
reported that activation of TRPC6-dependent Ca2+ signaling
facilitated endotoxin-induced lung vascular permeability and
inflammation (Tauseef et al., 2012). Moreover, TRPC6 deletion
in mice increased resistance to endotoxin-induced barrier
dysfunction and inflammation, and protected against sepsis-
induced lethality. In the kidney, acquired glomerular diseases
were associated with increased expression levels of TRPC6. It
has been reported that overexpression of TRPC6 in podocytes
was sufficient to cause a kidney disease consistent with focal
and segmental glomerulosclerosis (Krall et al., 2010). Though the
above studies were from non-neural tissues, they all indicated
that overexpression or activation of TRPC6 was involved in
disease-related damages in tissues and organs.
Consistent with the present finding, TRPC6 expression levels
in the retinal ganglion cells were increased 24 h after I/R
in rats (Wang et al., 2010). Similarly, TPRC6 levels were
increased in patients with glaucoma (Chen et al., 2013). Different
from the present findings, however, activation of TRPC6
before ischemia has been reported to have neuroprotective
effects on retinal ganglion cells (Wang et al., 2010). In
contrast, TRPC6 expression levels were decreased in the brain
after I/R and activation of TRPC6 had protective effects on
ischemic brain damage in rats (Du et al., 2010). Furthermore,
TRPC6 activator Hyperforin and Resveratrol has been shown
to suppress MCAO-induced brain damage via inhibition of
TRPC6 degradation in rats (Lin et al., 2013a,b). Thus far,
the exact reasons for these discrepancies among these studies
are not known. Possibly, different animal models, tissue types,
and approaches contributed to these discrepancies. Whereas
other studies used rat models, we used the TRPC6−/−
mouse model. Further investigation is needed to address these
discrepancies.
It should be mentioned that TRPC1 or TRPC3 are also
widely expressed in the nervous system and they have structural
similarities with TRPC6 (Riccio et al., 2002). In addition to
TRPC6, the expression level of TPRC1 in the brain tissue was
measured after I/R in WT mice and the TRPC3 expression level
Frontiers in Neuroscience | www.frontiersin.org 10 March 2017 | Volume 11 | Article 138
Chen et al. The Role of TRPC6 in Ischemia and OGD-Induced Neurotoxicity
FIGURE 7 | A schematic drawing to show the role of TRPC6 in I/R- and
ODG-induced Ca2+ influx via regulation of NMDARs. TRPC6 expression
was increased in neurons following I/R in mice brain and OGD in primary
cortical neurons. TRPC6 up-regulation following I/R and OGD induced cortical
neuronal death may in part through Na+ entry, leading to over-activation of
NMDA receptors, and causing an overload of Ca2+. Deletion of TRPC6
protects against cerebral ischemia-induced brain damage in vivo and OGD-
and excitatory neurotoxin-induced cell death in vitro. This protection is
mediated partially through TRPC6-mediated NMDA pathways.
in the primary cultured neurons following OGD in the early stage
of the present study. In contrast to TRPC6 expression as shown in
Figure 1, expression of TRPC1was not increased in the ipsilateral
cortex after I/R and TRPC3 expression was not increased in
OGD-treated cortical neurons (unpublished observations). These
initial observations lead to the selection of TRPC6, rather than
TRPC1 and TRPC3 in this study. Whether TRPC1 and TRPC3
may be involved in I/R-induced brain damage should be studied
in the future.
In summary, the present studies have demonstrated that
TRPC6 overexpression after I/R and following OGD treatment
may contribute to brain damage and to OGD- and neurotoxicity-
induced cell death. Activation of TRPC6 channels may increase
Ca2+ influx through NMDAR, which may lead to cell death
(Figure 7). Since TRPC6 channels are voltage-independent and
are not involved in the major neurotransmission, pharmacologic
interventions targeting at TRPC6 may potentially have fewer
side effects than direct blockade of NMDAR. Though this
study has provided a potential mechanism for the TRPC6
deletion protection against Ca2+ -induced neurotoxicity through
NMDAR, the present work has not yet determined whether
blockade of TRPC6 may have a greater protective effect than
directly blocking NMDAR. Such an important question needs to
be addressed in future studies.
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